Showing results (311-320 of 341) with videos related to
Sort By:
Pageof 35
Proceedings of the National Academy of Sciences of the United States of America|April 2, 1996
Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronateA Schmidt, S J Rutledge, N Endo, et al.The Journal of Clinical Investigation|October 1, 1983
Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cellsS B Rodan, K L Insogna, A M Vignery, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1985
Echocardiographic abnormalities following cardiac radiationD J Perrault, M Levy, J D Herman, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 25, 2016
123I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panelV Lewington, B Lambert, U Poetschger, et al.Molecular Endocrinology (Baltimore, Md.)|May 8, 2004
The LATS2/KPM tumor suppressor is a negative regulator of the androgen receptorMark Powzaniuk, Sheila McElwee-Witmer, Robert L Vogel, et al.Cancer|April 15, 1984
Radionuclide angiography and endomyocardial biopsy in the assessment of doxorubicin cardiotoxicityM N Druck, K Y Gulenchyn, W K Evans, et al.Proceedings of the National Academy of Sciences of the United States of America|January 6, 1999
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitroJ E Fisher, M J Rogers, J M Halasy, et al.Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Nonpeptide alpha(v)beta3 antagonists: identification of potent, chain-shortened 7-oxo RGD mimeticsAmy E Zartman, Le T Duong, Carmen Fernandez-Metzler, et al.Maturitas|August 15, 2009
Control of rat tail skin temperature regulation by estrogen receptor-beta selective ligandEvan E Opas, Angela Scafonas, Pascale V Nantermet, et al.Molecular Pharmacology|June 16, 2001
Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2)M Machwate, S Harada, C T Leu, et al.Pageof 35